The San Diego Supercomputer Center at the University of California, San Diego, is a recipient of this year’s HPCwire and Editors’ Choice Awards for its new Comet supercomputer that entered production earlier this year as a result of a National Science Foundation grant worth nearly $24 million including hardware and operating funds.
Bioengineer Todd Coleman, from the University of California, San Diego, has been named one of 100 outstanding individuals for 2015 by The Root, a premier news, opinion and culture site for African-American influencers. Other names on the list include tennis player Serena Williams, ballerina Misty Copeland and hip-hop artist Kendrick Lamar. Coleman will present his research at the prestigious TEDMED conference Nov. 18 to 20 in Palm Springs. His talk will focus on multi-disciplinary research and bioelectronics. He is part of the event’s Techno-Utopia session.
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired — permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Qualcomm has helped shape UC San Diego into what it is today—a catalyst for economic, social and scientific impact. Most recently, Qualcomm established an endowment for the UC San Diego School of Global Policy and Strategy’s 21st Century China Program.
Researchers at the University of California, San Diego report new insights into what nutrients fat cells metabolize to make fatty acids. The findings pave the way for understanding potential irregularities in fat cell metabolism that occur in patients with diabetes and obesity and could lead to new treatments for these conditions.
Peptides promise to be useful drugs, but they're too easily digested and can’t get into cells without help. Chemists at UC San Diego now show that peptides can be protected from digestion and delivered into cells without changing their biological function by rearranging them into dense brushes.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
